Developing New Sources of X-ray Imaging Contrast and Imaging Systems with Biomedical Applications at a Synchrotron
Friday April 17, 2009
Reception at 2:30pm in room 242
Dean Chapman
Distinguished Alumnus Seminar - University of Saskatchewan, Team Leader, Biomedical Imaging and Therapy Beamlines Project, Canadian Light Source
A synchrotron biomedical research facility is nearing completion at the
Canadian Light Source in Saskatoon, Saskatchewan. The Biomedical
Imaging and Therapy (BMIT) facility will provide high intensity, high
x-ray energy light for a wide variety of imaging and therapy programs.
This facility is now in the construction phase with some initial
operations which began late last year (December 2008).
Several imaging methods (absorption-edge subtraction imaging,
diffraction enhanced imaging, phase contrast imaging, and absorption
imaging) in projection and computed tomography modes as well as
monochromatic beam and filtered white beam therapy methods will be
available at this facility.
Much of the imaging work at this facility will rely on x-ray phase
contrast using methods developed in the past several years, primarily at
synchrotron facilities. One of the techniques that exploit phase
mechanisms is Diffraction Enhanced Imaging (DEI). This method develops
subject contrast from x-ray refraction and ultra-small angle x-ray
scattering (USAXS) as well as the usual x-ray attenuation and is easily
applied using synchrotron x-ray sources. The physics of the contrast
mechanisms, imaging system details as well as applications to
mammography, cartilage / joint imaging, and small animal imaging will be
presented.
Some progress has been made in developing laboratory based systems which
DEI and examples of imaging with them will be given along with some
details of the arrangements used.
Finally, an example of a new application of absorption edge imaging
combined with fluorescence imaging will be presented. This work has led
to the possibility of imaging gene expression in animal systems using
x-rays which could revolutionize some areas of genetic research.